Andy Christiansen
Analyst · Aaron Kessler with Raymond James. Please proceed with your question
Thank you, Lynne. We were extremely pleased with our results in Q1, which marked our return to year-over-year growth. Our existing business including the results of Dosh exceed our expectations. Before diving further into our results, I wanted to discuss our cash and liquidity position at the end of Q1, which includes our equity offering in the Dosh acquisition and where we expect to be following the close of Bridg. We ended Q1 with $614 million in cash and cash equivalents, compared to $293 million at the end of 2020. We expect to have over $215 million cash on a pro forma basis, after the Bridg acquisition, which we expect to close later this month. In addition, our loan facility, a 50 million remains undrawn at this time. Our balance sheet liquidity remains extremely strong following the Bridg deal. While we are always evaluating our capital structure, we see no immediate need to raise additional funds. Now turning to our Q1 performance. We’ll saw the usual seasonal decline from Q4 to Q1. Q1 landed at the high end of expectations before taking into account the partial month contribution from the Dosh acquisition. These strong results came despite the ongoing challenging environment in the UK to district COVID-19 lockdowns and continued limitations and travel. As we mentioned earlier, we saw strength in several industry verticals. What's also encouraging is the growing number of clients in our channel since the onset of the pandemic. While most of our new accounts are relatively small budgets, the increase in advertisers reflects the pivot we made in Q2 of 2020. And those will for a long-term health of the platform. As mentioned before, we believe the self service capabilities of our new platform will accelerate this trend overtime and give us a more scalable solution to onboard advertisers with budgets of all sizes. Billings increase 13% year-over-year year to $76.3 million, excluding the additional $1.3 million in billings from Dosh in the last 25 days of the quarter, our billing totaled $75 million which is at the high end of our guidance. Revenue totaled $53.2 million a 17% increase over Q1 of 2020. And as expected billings margins were in line with historical norms at 70%. Excluding the $0.5 million dollars of additional revenue from Dosh, our revenue totaled $32.7 million, which was near the high end of our guidance. U.S revenue increased 23% year-over-year, however, UK revenue was down 25%. Our UK business continued to meaningfully impacted by the pandemic as lockdowns implemented to slow the spread of new COVID-19 variants just started to unwind in April. We expect the UK to continue to unwind carefully anticipates on continued pressure our UK results in the near-term. Adjusted contribution was $24.3 million, an increase of 19% year-over-year. We don't expect adjusted contribution to significantly outpace revenue growth going forward. But it's worth noting that Dosh contracts in place today, for a lower level of partnership, and other third party costs. Adjusted EBITDA was a loss of $3.9 million, compared to a loss of $4 million in Q1 of 2020, excluding stock compensation Dosh contributed $1.3 million in operating expenses, expenses within R&D and sales increase on a year-over-year basis, and reflect investments made in the back half of 2020 to bring in several new leaders across the organization and increase our product development and analytical capabilities. We expect to generate a larger EBITDA loss in Q2 as our investment in Dosh is reflected for a full quarter. It's also worth noting that we include 70 of acquisition costs during the current quarter, and those costs are excluded from adjusted EBITDA. We expect additional acquisition and integration costs in the future, as we continue to integrate Dosh and close the acquisition of Bridg. As Lynne mentioned earlier, MAUs were 20% year-over-year to over $168 million. This was driven by the Wells Fargo launch accelerated organic growth from log end to check on similar and Dosh acquisition. U.S Bank will add several million and the U.S once fully launched. We also expect continued growth from Dosh as new partners come online throughout 2021. ARPU during the first quarter was $0.32 consistent with the prior year. We expect ARPU to increase on sequential and year-over-year basis throughout the rest of 2021 as our MAU stabilized and we continue to grow our revenue. We had 31.8 million shares outstanding at the end of Q1 compared to 27.8 million at the end of last year, which reflects the sale of 3.9 million new shares in March. Weighted average shares outstanding during the quarter was 29.3 million compared to 26.7 million during Q1 of 2020. Now turning to guidance, our guidance range remains a bit wider than usual, due to what may be an uneven recovery in the UK and continued uncertainty of when the expected rebound in travel and entertainment will occur. Also, while our guidance includes Dosh, does not include the results of Bridg, which has not yet closed. We expect billings in Q2 of between $85 million and $95 million, revenue of between $58 million and $65 million and adjusted contribution or between $26 million and $30 million. For the full year, we expect billings at between $380 million and $420 million, revenue of between $260 million and $285 million and adjusted contribution of between $117.5 million and $132.5 million. Again, these ranges include contributions from Dosh, and will incorporate Bridg's next quarter. While we have a lot of work ahead of us in 2021, we are very excited about the collective potential of Cardlytics, Dosh, and Bridg. In order to realize that full potential, we are making sure we have sufficient resources and investments to thoughtfully bring these companies together and create meaningful shareholder value. Our legacy business is strong and has a lot of momentum, and these acquisitions will not only sustain that momentum for years to come but will also open up new avenues for future growth. And with that, I'll turn it back over to Lynne.